Abstract:To analyze the invasion characteristics and to validate T descriptor of the tumor, node, metastasis (TNM) staging system in an independent cohort of patients with Masaoka-Koga stage III thymoma. A total of 179 patients diagnosed as Masaoka-Koga stage III thymoma from January 2000 to June 2018 were analyzed retrospectively. Among them, 94 patients underwent complete resection, 39 patients underwent incomplete resection and 46 patients underwent biopsy only. All patients were reclassified according to the 8th edition of TNM staging system. Kaplan-Meier method was used to calculate the cumulative survival rate, Log-rank method was used to compare between groups, and Cox regression was used for multivariate analysis. The median follow-up time was 50 months. The most common site of invasion was mediastinal pleura (154/179, 86%), followed by pericardium (91/179, 50.8%), great vessel (73/179, 40.8%), lung (65/179, 36.3%), phrenic nerve (19/179,10.6%) and chest wall (3/179, 1.7%). The proportion of great vessel invasion in complete resection group (14.9%) was significantly lower than that in the incomplete resection group (79.5%) and biopsy only group (60.9%, P < 0.001). After reclassification, 179 patients were assigned to T1b (22 cases), T2 (26 cases), T3 (102 cases) and T4 (29 cases). There were overall survival (OS) and progression free survival (PFS) difference between T2 and T3 (P = 0.021 and P = 0.003, respectively), while no significant OS or PFS difference was found between T1b and T2 (P = 0.656 and P = 0.210, respectively), T3 and T4 (P = 0.955 and P = 0.777, respectively). When T1b combined with T2 compared with T3 combined with T4, statistically significant difference was found in both OS (P = 0.001) and PFS (P <0.001). The multivariate analysis showed that T stage classification was not an independent prognostic factor for OS or PFS, while surgical completeness was the most important independent prognostic factor for both OS (P<0.001) and PFS (P<0.001). For Masaoka-Koga stage III thymoma, mediastinal pleura is the most common site of invasion. The invasion of mediastinal pleura, pericardium and lung has little effect on resectability, while great vessel involvement can significantly affect surgical resectability. The TNM staging system was not found to be an independent prognostic factor. Surgical completeness was the most important factor affecting prognosis.

Invasion Characteristics and Validation of the T Descriptor in the 8th Edition of TNM Staging System for Patients with Masaoka-Koga Stage III Thymoma

Impact of the TNM staging system for thymoma

Classification and staging of thymoma

Single-center evaluation of prognostic factors for thymoma treated by surgery: a retrospective study

Ct Staging And Preoperative Assessment Of Resectability For Thymic Epithelial Tumors

Surgical Treatment of Invasive Thymoma: a Prognostic Retrospective Study

Outcome of Multimodality Treatment for 188 Cases of Type B3 Thymoma

Surgical treatment of thymoma: an 11-year experience with 761 patients.

Treatment and Prognosis of Masaoka Stage 3 Thymic Carcinoma: a Retrospective Study of 32 Cases

The long-term outcome and prognostic factors analysis of multimodality treatment for 283 patients with thymoma

Comparison of the Masaoka-Koga Staging and the International Association for the Study of Lung Cancer/The International Thymic Malignancies Interest Group Proposal for the Tnm Staging Systems Based on the Chinese Alliance for Research in Thymomas Retrospective Database

Comparison of the Masaoka-Koga and the IASLC/ITMIG Proposal for the TNM Staging Systems Based on the Chinese Alliance for Research in Thymomas (chart) Retrospective Database

Comparison Of Surgical Approach And Extent Of Resection For Masaoka-Koga Stage I And Ii Thymic Tumours In Europe, North America And Asia: An International Thymic Malignancy Interest Group Retrospective Database Analysis

Prognostic Correlation Between Tumor Volume and Complete Resection of Thymoma at Different Masaoka-Koga Stages

Analysis of treatment and prognosis of 73 thymic carcinoma patients

Surgery in Masaoka Stage IV Thymic Carcinoma: a Propensity-Matched Study Based on the SEER Database.

Evaluation of the Proposed International Association for the Study of Lung Cancer (iaslc)/international Thymic Malignancies Interest Group (ITMIG) Staging Revisions in Thymic Well-Differentiated Neuroendocrine Carcinoma Patients.

Real-world study of treatment and outcome of type B2 + B3 thymoma: The neglected part of thymoma

Clinical analysis of postoperative radiotherapy in type B3 thymoma patients

Evaluation of the relationship between the eighth edition of TNM staging, the mMasoaka, and World Health Organization histopathological classification for thymoma

Preoperative CT Findings of Thymoma Are Correlated with Postoperative Masaoka Clinical Stage.